Article
Genomic Mechanisms of p210BCR-ABL Signaling
1 Aug 2004
Abstract excerpt
Chronic myelogenous leukemia (CML) results from a t(9,22) translocation, producing the p210(BCR-ABL) oncoprotein, a tyrosine kinase that causes transformation and chemotherapy resistance. To further understand mechanisms mediating chemotherapy resistance, we identified 556 differentially regulated genes in HL-60 cells stably expressing p210(BCR-ABL) versus those expressing an empty vector using cDNA macro- and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
